cyrusone inc (CONE:NASDAQ GS)

Financial Statements for cyrusone inc (CONE)

Currency in Millions of US Dollars	As of:	Dec 31 2009	Dec 31 2010	Dec 31 2011 Reclassified	Dec 31 2012	4 Year Trend
TOTAL REVENUES		74.1	127.5	181.7	220.8
Cost of Goods Sold		32.5	45.7	60.5	78.5
GROSS PROFIT		41.6	81.8	121.2	142.3
Selling General & Admin Expenses, Total		9.3	13.8	21.6	30.0
Depreciation & Amortization, Total		18.0	36.2	55.5	73.4
Other Operating Expenses		1.2	1.8	3.5	3.2
OTHER OPERATING EXPENSES, TOTAL		1.2	1.8	3.5	3.2
OPERATING INCOME		13.1	30.0	40.6	35.7
Interest Expense		-3.1	-11.5	-32.9	-41.8
Interest Expense, Total		-3.1	-11.5	-32.9	-41.8
Other Non-Operating Expenses, Total		--	--	-2.6	-5.7
Other Non-Operating Income (Expenses)		--	--	-2.6	-5.7
Merger & Restructuring Charges		--	-12.2	--	--
Gain (Loss) on Sale of Assets		--	-0.1	--	0.1
Other Unusual Items, Total		--	--	-1.4	-13.7
EBT, INCLUDING UNUSUAL ITEMS		10.0	6.2	3.7	-25.4
Income Tax Expense		3.9	2.7	2.2	-5.1
Earnings from Continuing Operations		6.1	3.5	1.5	-20.3
NET INCOME		6.1	3.5	1.5	-20.3
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		6.1	3.5	1.5	-20.3
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		6.1	3.5	1.5	-20.3

Report Data Issue

To contact CYRUSONE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.